Is 2% chlorhexidine gluconate in 70% isopropyl alcohol more effective at preventing central venous catheter–related infections than routinely used chlorhexidine gluconate solutions: A pilot multicenter randomized trial (ISRCTN2657745)?

American Journal of Infection Control

Volumn 44, Issue 8, 2016, Pages 948-949

  McCann, Margaret ^a   Fitzpatrick, Fidelma ^b,c   Mellotte, George ^a,d   Clarke, Michael ^a,e  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

^d ADELAIDE AND MEATH HOSPITAL   (Ireland)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

central venous catheters; chlorhexidine gluconate; clinical trial; Hemodialysis; infection prevention; skin cleansing

Indexed keywords

2 PROPANOL PLUS CHLORHEXIDINE GLUCONATE; CHLORHEXIDINE GLUCONATE; 2 PROPANOL; CHLORHEXIDINE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AGED; ANTISEPSIS; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFECTION PREVENTION; IRELAND; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MULTICENTER STUDY; OPEN STUDY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; AMBULATORY CARE; ANALOGS AND DERIVATIVES; CENTRAL VENOUS CATHETERIZATION; DISINFECTION; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

2-PROPANOL; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTI-INFECTIVE AGENTS, LOCAL; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHLORHEXIDINE; DISINFECTION; FEMALE; HUMANS; IRELAND; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 84962802898     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2016.02.019     Document Type: Article

References (6)

1. 1 Ravani, P., Palmer, S.C., Oliver, M.J., Quinn, R.R., MacRae, J.M., Tai, D.J., et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol 24 (2013), 465–473.
2. 2 Bray, B., Boyd, J., Daly, C., Donaldson, K., Doyle, A., Fox, J., et al. Vascular access type and risk of mortality in a national prospective cohort of haemodialysis patients. QJM 105 (2012), 1097–1103.
3. 3 McCann, M., Moore, Z., Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. Cochrane Database Syst Rev(1), 2010 CD006894.
4. 4 Mermel, L., Allon, M., Bouza, E., Craven, D., Flynn, P., O'Grady, N., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis 49 (2009), 1–45.
5. 5 CDC/NHSN, The National Healthcare Safety Network (NHSN) Manual, Patient Safety Component Protocol. 2009, CDC/NHSN, Atlanta (GA).
6. 6 Yahav, D., Rozen-Zvi, B., Gafter-Gvili, A., Leibovici, L., Gafter, U., Paul, M., Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomised controlled trials. Clin Infect Dis 47 (2008), 83–93.